Skip to content

Paramedic supplied 'Take Home' Naloxone: a feasibility study

Paramedic Administered Take Home kits: Feasible Intervention for Naloxone Distribution in Emergency Response (PATHFINDER) to opioid overdose: a feasibility study for a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN98216498
Enrollment
100
Registered
2012-11-15
Start date
2012-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin/opioid overdose, prehospital emergency Mental and Behavioural Disorders Mental and behavioural disorders due to use of opioids

Interventions

Following a 999 call and resuscitation for an opioid poisoning paramedics will supply 'Take Home' Naloxone (THN) to patients, for administration to peers or family members in a subsequent emergency. P

Sponsors

Welsh Ambulance Services NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient attended following a 999 call by a paramedic that normally operates in the Cardiff & Vale of Glamorgan area, has volunteered to participate and is trained to provide THN to patients under the auspices of the THN PGD. 2. Patient is 18 years of age or older 3. Patient has regained full consciousness (GCS 15) and demonstrates full mental capacity following treatment for a suspected opiate overdose

Exclusion criteria

Exclusion criteria: 1. Patient attended by a paramedic not trained to provide the intervention 2. Patient is 17 years of age or younger 3. Patient treated for opioid overdose, but fails to regain full consciousness/full mental capacity

Design outcomes

Primary

MeasureTime frame
In this feasibility study it is inappropriate to state the primary outcome, as part of the purpose of this study is to help us to define the primary outcome for a definitive trial. Linked to the study research questions, the outcomes to be included are as follows: Processes and outcomes of care for patients attended by participating paramedics Numbers and proportions of patients: 1.Eligible/not eligible 2. Offered THN/not offered THN 3. THN protocol followed/not followed by crew (compliance) 4. Accepted/did not accept intervention 5. Attended A&E/did not attend A&E 6. Suffered further overdose(s) and attended by ambulance within the study period 7. Died (of any cause/of opiate poisoning) during the study period? Time 1. From 999 call to ambulance free for next call (job cycle time) 2. Total on scene 3. To next overdose 4. Patient reported 5. 999 call Feasibility of service user follow up: 1. Number and proportion of eligible patients consented to follow-up 2. Number and proportion successfully contacted (telephone/post) 3. Number and proportion that resulted in a completed questionnaire?

Secondary

MeasureTime frame
1. Patient experience in relation to possession and usage of THN and their views on the initiative 2. Paramedics views of the feasibility of the THN initiative including their own training; the training they provided to patients; operational practicalities; safety concerns

Countries

United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026